325 related articles for article (PubMed ID: 25898936)
21. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.
Desouki MM; Lioyd J; Xu H; Cao D; Barner R; Zhao C
Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
[TBL] [Abstract][Full Text] [Related]
23. A novel case of concurrent renal tumors: chromophobe renal cell carcinoma and carcinoid tumor of the kidney with brief review of renal neuroendocrine tumors.
Roy S; Hooda S; Huang GJ; Pantanowitz L; Parwani AV
Int J Surg Pathol; 2012 Oct; 20(5):531-5. PubMed ID: 22456871
[TBL] [Abstract][Full Text] [Related]
24. Primary carcinoid tumors of the kidney.
Romero FR; Rais-Bahrami S; Permpongkosol S; Fine SW; Kohanim S; Jarrett TW
J Urol; 2006 Dec; 176(6 Pt 1):2359-66. PubMed ID: 17085102
[TBL] [Abstract][Full Text] [Related]
25. Analysis of Clinicopathological Features and Prognostic Factors in 39 Cases of Bladder Neuroendocrine Carcinoma.
Zhou HH; Liu LY; Yu GH; Qu GM; Gong PY; Yu X; Yang P
Anticancer Res; 2017 Aug; 37(8):4529-4537. PubMed ID: 28739749
[TBL] [Abstract][Full Text] [Related]
26. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
[TBL] [Abstract][Full Text] [Related]
27. Renal carcinoid tumor: a clinicopathologic study of 21 cases.
Hansel DE; Epstein JI; Berbescu E; Fine SW; Young RH; Cheville JC
Am J Surg Pathol; 2007 Oct; 31(10):1539-44. PubMed ID: 17895755
[TBL] [Abstract][Full Text] [Related]
28. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
Rouquette Lassalle I
Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
[TBL] [Abstract][Full Text] [Related]
29. [Case of primary renal carcinoid tumor with hemorrhage].
Kubota Y; Seike K; Maeda S; Tashiro K
Hinyokika Kiyo; 2010 Apr; 56(4):225-8. PubMed ID: 20448447
[TBL] [Abstract][Full Text] [Related]
30. Molecular alterations of neuroendocrine tumours of the lung.
Rossi G; Bertero L; Marchiò C; Papotti M
Histopathology; 2018 Jan; 72(1):142-152. PubMed ID: 29239031
[TBL] [Abstract][Full Text] [Related]
31. [Neuroendocrine neoplasms of the mediastinum].
Brcic L; Heidinger M; Popper H
Pathologe; 2016 Sep; 37(5):434-40. PubMed ID: 27507161
[TBL] [Abstract][Full Text] [Related]
32. hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors.
Ye B; Cappel J; Findeis-Hosey J; McMahon L; Yang Q; Xiao GQ; Xu H; Li F
Hum Pathol; 2016 Feb; 48():142-7. PubMed ID: 26596584
[TBL] [Abstract][Full Text] [Related]
33. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
[TBL] [Abstract][Full Text] [Related]
34. Primary carcinoid of the kidney. Immunohistochemical and ultrastructural studies of five patients.
Raslan WF; Ro JY; Ordonez NG; Amin MB; Troncoso P; Sella A; Ayala AG
Cancer; 1993 Nov; 72(9):2660-6. PubMed ID: 8402487
[TBL] [Abstract][Full Text] [Related]
35. Carcinoid tumor associated with adjacent dysplastic columnar epithelium in the renal pelvis: A case report and literature review.
Kim SS; Choi C; Kang TW; Choi YD
Pathol Int; 2016 Jan; 66(1):42-6. PubMed ID: 26644387
[TBL] [Abstract][Full Text] [Related]
36. Kidney carcinoid tumor: Histological, immunohistochemical and ultrastructural features.
Gu X; Cheng M; Herrera GA
Ultrastruct Pathol; 2018; 42(1):18-22. PubMed ID: 29192809
[TBL] [Abstract][Full Text] [Related]
37. [Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)].
Kristiansen G; Delahunt B; Srigley JR; Lüders C; Lunkenheimer JM; Gevensleben H; Thiesler T; Montironi R; Egevad L
Pathologe; 2015 May; 36(3):310-6. PubMed ID: 25398389
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical and fine structural characterization of primary carcinoid tumors of the larynx.
Dieler R; Dämmrich J
Eur Arch Otorhinolaryngol; 1995; 252(4):229-35. PubMed ID: 7546678
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.
Yeh YC; Chou TY
J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337
[TBL] [Abstract][Full Text] [Related]
40. Neuron-Specific Enolase as an Immunohistochemical Marker Is Better Than Its Reputation.
Mjønes P; Sagatun L; Nordrum IS; Waldum HL
J Histochem Cytochem; 2017 Dec; 65(12):687-703. PubMed ID: 28972818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
